Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank80
3Y CAGR+65.3%
5Y CAGR+89.0%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+65.3%/yr
Annual compound
5Y CAGR
+89.0%/yr
Recent deceleration
Percentile
P80
Within normal range
vs 5Y Ago
24.1x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$6.75M-23.3%
2024$8.79M+188.4%
2023$3.05M+103.9%
2022$1.49M+108.1%
2021$-18.55M-6726.1%
2020$280000.00-